Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: The ProtecT three-arm RCT

<p><strong>Background:</strong><br /> Prostate cancer is the most common cancer among men in the UK. Prostate-specific antigen testing followed by biopsy leads to overdetection, overtreatment as well as undertreatment of the disease. Evidence of treatment effectiveness has la...

Ամբողջական նկարագրություն

Մատենագիտական մանրամասներ
Հիմնական հեղինակներ:	Hamdy, FC, Donovan, JL, Lane, JA, Mason, M, Metcalfe, C, Peter Holding, Wade, J, Noble, S, Garfield, K, Young, G, Davis, M, Peters, TJ, Turner, EL, Martin, RM, Oxley, J, Robinson, M, Staffurth, J, Walsh, E, Blazeby, J, Bryant, R, Bollina, P, Catto, J, Doble, A, Doherty, A, Gillatt, D, Gnanapragasam, V, Hughes, O, Kockelbergh, R, Kynaston, H, Paul, A, Paez, E, Powell, P, Prescott, S, Rosario, D, Rowe, E, Neal, D
Այլ հեղինակներ:	ProtecT Study Group
Ձևաչափ:	Journal article
Լեզու:	English
Հրապարակվել է:	NIHR Journals Library 2020

Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: The ProtecT three-arm RCT

Նմանատիպ նյութեր